Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority claimed from PCT/EP1995/004393external-prioritypatent/WO1996015129A1/fr
Publication of CA2204030A1publicationCriticalpatent/CA2204030A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'invention concerne des imidazodiazépines substituées de façon basique et possédant la formule générale (I). On peut utiliser ces composés en tant que substances actives anxiolytiques et/ou anticonvulsivantes et/ou myorelaxantes et/ou hypno-sédatives.
CA 22040301994-11-111995-11-08Oxazolyl-, thiazolylimidazo-benzo- et thienodiazepines et leur utilisation en tant que medicaments
AbandonedCA2204030A1
(fr)
3-(1,2,4-oxadiazolyl) imidazo [1,5-a] quinazolineamine and quinoxalineamine compounds, their preparation and pharmaceutical compositions containing them